The Use of Cardiotonic Drugs in Neonates
| Autor: | Igor Brbre, Eugene Michael Dempsey, Heike Rabe |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Inotrope
Drug Heart Defects Congenital medicine.medical_specialty Neonatal intensive care unit Cardiotonic Agents RJ Vasopressins media_common.quotation_subject Dopamine Persistent Fetal Circulation Syndrome 03 medical and health sciences Norepinephrine 0302 clinical medicine Adrenal Cortex Hormones 030225 pediatrics Dobutamine Intensive Care Units Neonatal medicine Humans Vasoconstrictor Agents 030212 general & internal medicine Dosing Intensive care medicine Simendan media_common Asphyxia Neonatorum business.industry Cardiotonic drugs Infant Newborn Obstetrics and Gynecology Shock Shock (circulatory) Pediatrics Perinatology and Child Health medicine.symptom Hypotension Neonatal Sepsis business Perfusion medicine.drug Milrinone |
| Zdroj: | Clinics in perinatology. 46(2) |
| ISSN: | 1557-9840 0095-5108 |
| Popis: | There is a distinct lack of age-appropriate cardiotonic drugs, and adult derived formulations continue to be administered, without evidence-based knowledge on their dosing, safety, efficacy, and long-term effects. Dopamine remains the most commonly studied and prescribed cardiotonic drug in the neonatal intensive care unit (NICU), but evidence of its effect on endorgan perfusion still remains. Unlike adult and pediatric critical care, there are significant gaps in our knowledge on the use of various cardiotonic drugs in various forms of circulatory failure in the NICU. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|